Modeling exopeptidase activity from LC-MS data

Journal of Computational Biology

Volumn 16, Issue 2, 2009, Pages 395-406

  Kluge, Bogusaw ^a   Gambin, Anna ^a   Niemiro, Wojciech ^b  

^a UNIVERSITY OF WARSAW   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Exopeptidase activity; Liquid chromatography mass spectrometry; Markov chain Monte Carlo; Proteomics; Stochastic modeling

Indexed keywords

EXOPEPTIDASE;

ALGORITHM; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEOMICS; VALIDATION STUDY;

BAYES THEOREM; CHROMATOGRAPHY, LIQUID; EXOPEPTIDASES; HUMANS; MASS SPECTROMETRY; MATHEMATICS; MODELS, BIOLOGICAL; NEOPLASMS; PEPTIDES; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 59649103870     PISSN: 10665277     EISSN: None     Source Type: Journal    
DOI: 10.1089/cmb.2008.22TT     Document Type: Article

References (31)

1. Adam, B.L., Qu, Y., Davis, J.W., et al. 2002. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62, 3609-3614.
2. Aitchison, J., and Egozcue, J.J. 2005. Compositional data analysis: where are we and where should we be heading? Math. Geol. 37, 829-850.
3. Breiman, L. 2001. Random forests. Mach. Learn. 45, 5-32.
4. Ciliberto, A., Capuani, F., and Tyson, J.J. 2007. Modeling networks of coupled enzymatic reactions using the total quasi-steady state approximation. PLoS Comput. Biol. 3, e45.
5. Diamandis, E.P. 2003. Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin. Chem. 49, 1272-1275.
6. Diamandis, E.P. 2004. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 3, 367-378.
7. Diamandis, E.P. 2006. Peptidomics for cancer diagnosis: present and future. J. Proteome Res. 5, 2079-2082.
8. Efron, B., and Tibshirani, R. 1997. Improvements on cross-validation: the .632+ bootstrap method. J. Am. Stat. Assoc. 92, 548-560.
9. Gambin, A., Dutkowski, J., Karczmarski, J., et al. 2007. Automated reduction and interpretation of multidimensional mass spectra for analysis of complex peptide mixtures. Int. J. Mass Spectrom. 260, 20-30.
10. Geurts, P., Fillet, M., de Seny, D., et al. 2005. Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics 21, 3138-3145.
11. Hu, J., Coombes, K.R., Morris, J.S., et al. 2005. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief. Funct. Genomic Proteomic 3, 322-331.
12. Jacobs, I.J., and Menon, U. 2004. Progress and challenges in screening for early detection of ovarian cancer. Mol. Cell. Proteomics 3, 355-366.
13. Koomen, J.M., Li, D., Xiao, L.-C., et al. 2005. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Proteome Res. 4, 972-981.
14. Leeman, M.F., Curran, S., and Murray, G.I. 2003. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J. Pathol. 201, 528-534.
15. Li, J., Zhang, Z., Rosenzweig, J., et al. 2002. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48, 1296-1304.
16. Lilien, R.H., Farid, H., and Donald, B.R. 2003. Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum. J. Comput. Biol. 10, 925-946.
17. Liotta, L.A., and Petricoin, E.F. 2006. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J. Clin. Invest. 116, 26-30.
18. Mallick, P., Schirle, M., Chen, S.S., et al. 2007. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25, 125-131.
19. Marshall, J., Kupchak, P., Zhu, W., et al. 2003. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2, 361-372.
20. Masaki, T., Matsuoka, H., Sugiyama, M., et al. 2001. Matrilysin (mmp-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br. J. Cancer 84, 1317-1321.
21. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., et al. 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577.
22. Rawlings, N.D., and Barrett, A.J. 2000. Merops: the peptidase database. Nucleic Acids Res. 28, 323-325.
23. Reznik, S.E., and Fricker, L.D. 2001. Carboxypeptidases from a to z: implications in embryonic development and wnt binding. Cell. Mol. Life Sci. 58, 1790-1804.
24. Schölkopf, B., and Smola, A.J. 2002. Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond. MIT Press, Cambridge, MA.
25. Tibshirani, R., Hastie, T., Narasimhan, B., et al. 2004. Sample classification from protein mass spectrometry, by "peak probability contrasts." Bioinformatics 20, 3034-3044.
26. Verrills, N.M. 2006. Clinical proteomics: present and future prospects. Clin. Biochem. Rev. 27, 99-116.
27. Villanueva, J., Martorella, A., Lawlor, K., et al. 2006a. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol. Cell. Proteomics 5, 1840-1852.
28. Villanueva, J., Nazarian, A., Lawlor, K., et al. 2008. A sequence-specific exopeptidase activity test (sseat) for "functional" biomarker discovery. Mol. Cell. Proteomics 7, 509-518.
29. Villanueva, J., Shaffer, D.R., Philip, J., et al. 2006b. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 116, 271-284.
30. Wu, B., Abbott, T., Fishman, D., et al. 2003. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics 19, 1636-1643.
31. Yu, J.S., Ongarello, S., Fiedler, R., et al. 2005. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics 21, 2200-2209.